Neurones (PA:NRO) — Stock Price

€39.00 EUR
▲ 3.04% today

Neurones (PA:NRO) is currently trading at €39.00 EUR, up 3.04% today. Over the past 52 weeks, shares have ranged between €33.65 and €44.70. This page tracks Neurones's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Neurones (NRO) total market value.

Neurones (NRO) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Neurones's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Neurones Income Statement — Revenue, Profit & Earnings by Year

Neurones's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €857.20 Million €810.40 Million €741.17 Million €665.38 Million €579.88 Million
Cost of Revenue €767.13 Million €421.59 Million €394.42 Million €583.74 Million €510.14 Million
Gross Profit €90.04 Million €388.76 Million €346.76 Million €81.64 Million €69.73 Million
Research & Development
SG&A €437.65 Million €408.08 Million €577.45 Million €170.82 Million
Total Operating Expenses €17.71 Million €310.84 Million €270.90 Million €236.22 Million €195.00 Million
Operating Income €72.33 Million €77.90 Million €75.86 Million €72.89 Million €61.57 Million
EBITDA €90.32 Million €85.92 Million €96.63 Million €88.72 Million €76.23 Million
EBIT €72.33 Million €77.90 Million €80.73 Million €73.31 Million €61.43 Million
Interest Expense €1.20 Million €1.65 Million €1.43 Million €1.70 Million €966.00K
Income Before Tax €82.60 Million €88.10 Million €80.77 Million €72.86 Million €61.76 Million
Income Tax Expense €20.75 Million €24.90 Million €22.18 Million €21.09 Million €18.82 Million
Net Income €61.90 Million €52.50 Million €49.41 Million €44.24 Million €37.71 Million

Neurones Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Neurones's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €749.03 Million €725.69 Million €674.25 Million €616.22 Million €567.82 Million
Total Current Assets €608.53 Million €588.11 Million €545.81 Million €506.57 Million €464.13 Million
Cash & Equivalents €195.35 Million €169.60 Million
Short-term Investments €276.15 Million €-65.00K €195.35 Million €169.60 Million
Net Receivables €248.92 Million €216.82 Million €207.54 Million €192.23 Million €165.66 Million
Inventory €700.00K €267.00K €709.00K €353.00K €887.00K
Property, Plant & Equipment €60.53 Million €58.73 Million €49.80 Million €46.10 Million
Goodwill €60.93 Million €56.53 Million €51.67 Million €45.02 Million €44.41 Million
Total Liabilities €284.16 Million €289.52 Million €266.34 Million €240.63 Million €214.90 Million
Total Current Liabilities €250.06 Million €252.66 Million €228.92 Million €207.10 Million €184.56 Million
Long-term Debt €2.05 Million €1.51 Million €110.00K €204.00K
Net Debt €-303.82 Million €-284.47 Million €-253.78 Million €-236.49 Million €-229.85 Million
Total Stockholder Equity €399.98 Million €378.10 Million €354.39 Million €330.58 Million €311.56 Million
Retained Earnings €371.37 Million €52.56 Million €49.41 Million €288.19 Million €270.65 Million

Neurones Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Neurones generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €80.77 Million €84.38 Million €72.08 Million €54.97 Million €64.50 Million
Capital Expenditures €10.44 Million €12.04 Million €17.98 Million €10.61 Million €6.58 Million
Free Cash Flow €70.33 Million €72.34 Million €54.09 Million €44.36 Million €57.92 Million
Investing Cash Flow €-21.16 Million €-19.69 Million €-21.57 Million €-12.26 Million €-10.62 Million
Financing Cash Flow €-45.11 Million €-34.48 Million €-27.06 Million €-36.08 Million €-55.42 Million
Dividends Paid €31.62 Million €29.13 Million €26.65 Million €24.22 Million €48.42 Million
Stock-Based Compensation €5.11 Million €5.60 Million €3.36 Million €1.99 Million
Depreciation €17.99 Million €17.66 Million €16.76 Million €16.57 Million €14.68 Million
Change in Cash €231.92 Million €30.57 Million €23.48 Million €6.89 Million €-1.42 Million

Neurones Earnings History — EPS Actual vs. Analyst Estimates

Track Neurones's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Sep 09, 2026
May 06, 2026 0.00 0.00
Mar 11, 2026
Nov 05, 2025 0.00 0.00
Sep 10, 2025 0.93 0.00
Apr 28, 2025 1.15 0.00
Mar 05, 2025 0.00 0.00
Nov 06, 2024 0.00 0.00